<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">RUDN Journal of Medicine</journal-id><journal-title-group><journal-title xml:lang="en">RUDN Journal of Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российского университета дружбы народов. Серия: Медицина</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-0245</issn><issn publication-format="electronic">2313-0261</issn><publisher><publisher-name xml:lang="en">Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">24435</article-id><article-id pub-id-type="doi">10.22363/2313-0245-2020-24-3-207-217</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>IMMUNOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ИММУНОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Immunopathogenetic features and prognostic criteria for severe hemorrhagic fever with renal syndrome</article-title><trans-title-group xml:lang="ru"><trans-title>Иммунопатогенетические особенности и прогностические критерии тяжелого течения геморрагической лихорадки с почечным синдромом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ivanov</surname><given-names>M. F</given-names></name><name xml:lang="ru"><surname>Иванов</surname><given-names>М. Ф</given-names></name></name-alternatives><email>iri.balm@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Balmasova</surname><given-names>I. P</given-names></name><name xml:lang="ru"><surname>Балмасова</surname><given-names>И. П</given-names></name></name-alternatives><email>iri.balm@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zhestkov</surname><given-names>A. V</given-names></name><name xml:lang="ru"><surname>Жестков</surname><given-names>А. В</given-names></name></name-alternatives><email>iri.balm@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Samara State Medical University</institution></aff><aff><institution xml:lang="ru">Самарский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">A.I. Yevdokimov Moscow State University of Medicine and Dentistry</institution></aff><aff><institution xml:lang="ru">Московский государственный медико-стоматологический университет им. А.И. Евдокимова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2020</year></pub-date><volume>24</volume><issue>3</issue><issue-title xml:lang="en">VOL 24, NO3 (2020)</issue-title><issue-title xml:lang="ru">ТОМ 24, №3 (2020)</issue-title><fpage>207</fpage><lpage>217</lpage><history><date date-type="received" iso-8601-date="2020-08-26"><day>26</day><month>08</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Ivanov M.F., Balmasova I.P., Zhestkov A.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, Иванов М.Ф., Балмасова И.П., Жестков А.В.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Ivanov M.F., Balmasova I.P., Zhestkov A.V.</copyright-holder><copyright-holder xml:lang="ru">Иванов М.Ф., Балмасова И.П., Жестков А.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.rudn.ru/medicine/article/view/24435">https://journals.rudn.ru/medicine/article/view/24435</self-uri><abstract xml:lang="en"><p>Aim. Assessment of the features of cellular immunological mechanisms at the early stage of HFRS of varying severity and development of prognostic criteria for the risk of a severe course of the infectious process. Materials and methods. An immunological blood test (flow cytofluorimetry method) was performed in 12 patients with severe HFRS and 53 patients with moderate course in the dynamics of the disease. Statistical data processing was performed based on the SPSS software package. Results. At the initial stages of HFRS, immunological features of the severe course of the disease were established in the form of a higher content of T-helper and regulatory T-cells in the blood and a reduced number of CTL, including their activated pool. Based on these changes, an immunological prognostic coefficient of HFRS was developed, which allows determining the risk of severe course in the early days (febrile period) of the disease with high prognostic accuracy. Conclusion. The results obtained allowed us to identify previously unknown features of the immune process at the initial stages of HFRS development, which allowed us to propose a new approach to predicting the severe course of the disease.</p></abstract><trans-abstract xml:lang="ru"><p>Актуальность. Геморрагическая лихорадка с почечным синдромом - острое вирусное природноочаговое заболевание, проявляющееся геморрагическим синдромом и острой почечной недостаточностью, имеющее сложный иммунопатогенез и склонность к тяжелому течению. Цель. Оценка особенностей клеточно-иммунологических механизмов на ранних этапах ГЛПС разной степени тяжести и разработка на этой основе прогностических критериев риска тяжелого течения инфекционного процесса. Материалы и методы. Проведено иммунологическое исследование крови (метод проточной цитофлуориметрии) 12 больных с тяжелым течением ГЛПС и 53 пациентов со среднетяжелым течением в динамике заболевания. Статистическая обработка данных проведена на основе пакета программ SPSS. Результаты. На начальных этапах ГЛПС установлены иммунологические особенности тяжелого течения заболевания в виде более высокого содержания в крови Т-хелперов и регуляторных Т-клеток и сниженного количества ЦТЛ, включая их активированный пул. На основе отмеченных сдвигов разработан иммунологический прогностический коэффициент ГЛПС, позволяющий с высокой прогностической точностью определять риск тяжелого течения в первые дни (лихорадочный период) заболевания. Заключение. Полученные результаты позволили выявить неизвестные ранее особенности иммунного процесса на начальных этапах развития ГЛПС, что позволило предложить новый подход к прогнозированию тяжелого течения заболевания.</p></trans-abstract><kwd-group xml:lang="en"><kwd>hemorrhagic fever with renal syndrome (HFRS)</kwd><kwd>severe prognosis</kwd><kwd>immunopathogenesis</kwd><kwd>lymphocyte phenotypes</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>геморрагическая лихорадка с почечным синдромом (ГЛПС)</kwd><kwd>прогноз тяжелого течения</kwd><kwd>иммунопатогенез</kwd><kwd>фенотипы лимфоцитов</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Valishin D.A., Murzabayeva R.T., Galimov R.R., Shestakova I.V. Hemorrhagic fever with renal syndrome in adults: clinical recommendations. Moscow: The non-profit partnership “National Scientific Society of Infectious Disease”; 2014. (in Russ).</mixed-citation><mixed-citation xml:lang="ru">Валишин Д.А., Мурзабаева Р.Т., Галимов Р.Р., Шестакова И.В. Геморрагическая лихорадка с почечным синдромом у взрослых: клинические рекомендации. Москва: Некоммерческое партнерство «Национальное научное общество инфекционистов». 2014.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Conner SD, Schmid SL. Regulated portals of entry into the cells. Nature. 2003;422(6927):37—44. doi: 10.1038/nature01451 3. Guterres A., de Oliveira C.R., Fernandes J., de Lemos R.S.E. The mystery of the phylogeographic structural pattern in rodent-borne hantaviruses. Phylogenetics and Molecular Evolution.2019;146:35—43. doi: 10.1016/j.ympev.2019.03.020</mixed-citation><mixed-citation xml:lang="ru">Conner S.D., Schmid S.L. Regulated portals of entry into the cells. Nature. 2003. Vol. 422. N6927. P. 37-44.doi: 10.1038/nature01451</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Hunafina D.H., Galieva A.T, Shaykhullin A.R. Hemorrhagic fever with renal syndrome. Modern Epidemiology.Medical Almanac. 2009;(2):154—156. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Guterres A., de Oliveira C.R., Fernandes J., de Lemos R.S.E. The mystery of the phylogeographic structural pattern in rodent-borne hantaviruses. Phylogenetics and Molecular Evolution. 2019. Vol. 146 P. 35-43. doi: 10.1016/j.ympev.2019.03.020</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Mitrofanova N.N., Melnikov V.L., Zolina N.F., Skorokhodova E.D. Analysis of clinical and epidemiological and epizootic features of the incidence of hemorrhagic fever with renal syndrome in the Penza region. Izvestia of highereducation institutions. Volga region. Medical science. 2009;3(11):109—116. (in Russ).</mixed-citation><mixed-citation xml:lang="ru">Хунафина Д.Х., Галиева А.Т., Шайхуллина Л.Р. Геморрагическая лихорадка с почечным синдромом. Современная эпидемиология. Медицинский альманах. 2009. № 2. С. 154-156.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Alekhin E.K., Kamilov F.H, Hunifina D.H. Hemorrhagic fever with renal syndrome. Bashkortostan Medical Gazette. 2013;(5):24—31. (in Russ).</mixed-citation><mixed-citation xml:lang="ru">Митрофанова Н.Н., Мельников В.Л., Золина Н.Ф., Скороходова Е.Д. Анализ клинико-эпидемиологических и эпизоотических особенностей заболеваемости геморрагической лихорадкой с почечным синдромом на территории Пензенской области. Известия высших учебных заведений. Поволжский регион. Медицинские науки. 2009. № 3 (11). С. 109-116.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Morozov V.G., Ishmukhametov A.A., Dzagurova T.K., Tkachenko E.A. Clinical features of hemorrhagic fever with renal syndrome in Russia. Infectious diseases. 2017;(5):156—161. (in Russ).</mixed-citation><mixed-citation xml:lang="ru">Алехин Е.К., Камилов Ф.Х., Хунафина Д.Х. Геморрагическая лихорадка с почечным синдромом. Медицинский вестник Башкортостана. 2013. № 5. С. 24-31.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Jonsson C.B., Figueiredo L.T., Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clinical Microbiology Reviews. 2010;23:412—441. doi: 10.1128/ CMR.00062—09</mixed-citation><mixed-citation xml:lang="ru">Морозов В.Г., Ишмухаметов А.А., Дзагурова Т.К., Ткаченко Е.А. Клинические особенности геморрагической лихорадки с почечным синдромом в России. Инфекционные болезни. 2017. № 5. С. 156-161.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Goeijenbier M., Wagenaar J., Goris M., Martina B. Rodentborne hemorrhagic fevers: under-recognized, widely spread and preventable — epidemiology, diagnostics and treatment. Critical Reviews in Microbiology. 2013;39(1):26—42. doi: 10.3109/1040841X.2012.686481</mixed-citation><mixed-citation xml:lang="ru">Jonsson C.B., Figueiredo L.T., Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clinical Microbiology Reviews. 2010. Vol.23. P. 412-441. doi: 10.1128/ CMR.00062-09</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Pensiero M.N., Sharefkin J.B., Dieffenbach C.W., Hay J. Hantaan virus infection of human endothelial cells. Journal of Virology. 1992;66(10):5929—5936. doi: 10.1128/jvi.66.10.5929— 5936.1992</mixed-citation><mixed-citation xml:lang="ru">Goeijenbier M., Wagenaar J., Goris M., Martina B. Rodentborne hemorrhagic fevers: under-recognized, widely spread and preventable - epidemiology, diagnostics and treatment. Critical Reviews in Microbiology. 2013. Vol. 39, N1. P. 26-42. doi: 10.3109/1040841X.2012.686481</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Krautkrаmer E., Grouls S., Stein N., Reiser J., Zeiler M. Pathogenic old world hantaviruses infect renal glomerular and tubular cells and induce disassembling of cell-to-cell contacts. Journal of Virology. 2011;85(19):9811—9823. doi:10.1128/JVI.00568—11</mixed-citation><mixed-citation xml:lang="ru">Pensiero M.N., Sharefkin J.B., Dieffenbach C.W., Hay J. Hantaan virus infection of human endothelial cells. Journal of Virology. 1992. Vol. 66. N10. P. 5929-5936. doi: 10.1128/jvi.66.10.5929-5936.1992</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Manigold T., Vial P. Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology. Schweizerische medizinische Wochenschrift. 2014;144:13937—13955. doi: 10.4414/smw.2014.13937</mixed-citation><mixed-citation xml:lang="ru">Krautkrаmer E., Grouls S., Stein N., Reiser J., Zeiler M. Pathogenic oldworld hantaviruses infect renal glomerular and tubular cells and induce disassembling of cell-to-cell contacts. Journal of Virology. 2011. Vol. 85. N 19. P. 9811-9823. doi:10.1128/JVI.00568-11</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Jiang H., Du H., Wang L.M., Wang P.Z. Hemorrhagic fever with renal syndrome: pathogenesis and clinical picture. Frontiers in Cellular and Infection Microbiology. 2916;6:1—14. doi: 10.3389/fcimb.2016.0000</mixed-citation><mixed-citation xml:lang="ru">Manigold T., Vial P. Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology. Schweizerische medizinische Wochenschrift. 2014. Vol. 144. P. 13937-13955. doi: 10.4414/smw.2014.13937</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Gorbunova, E.E., Gavrilovskaya I.N., Pepini T., Mackow E.R. VEGFR2 and Src kinase inhibitors suppress Andes Virusinduced endothelial cell permeability. Journal of Virology. 2011;85(5):2296—2303. doi: 10.1128/JVI.02319—10</mixed-citation><mixed-citation xml:lang="ru">Jiang H., Du H., Wang L.M., Wang P.Z. Hemorrhagic fever with renal syndrome: pathogenesis and clinical picture. Frontiers in Cellular and Infection Microbiology. 2916. Vol. 6. P. 1-14. doi: 10.3389/fcimb.2016.0000</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Yu Z., Zhou N., Li A., Chen J., Chen H., He C., et al. Performance assessment of the SAPS II and SOFA scoring systems in Hanta virus Hemorrhagic Fever with Renal Syndrome. International Journal of Infectious Diseases. 2017;63:88—94. doi: 10.1016/j. ijid.2017.08.003</mixed-citation><mixed-citation xml:lang="ru">Gorbunova, E.E., Gavrilovskaya I.N., Pepini T., Mackow E.R. VEGFR2 and Src kinase inhibitors suppress Andes Virus-induced endothelial cell permeability. Journal of Virology. 2011. Vol. 85. N 5. P. 2296-2303. doi: 10.1128/JVI.02319-10</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Murphy K., Travers P., Walport M., editors. Janeway’s Immunobiology. 7nd ed. New York: Garland Science, 2011.</mixed-citation><mixed-citation xml:lang="ru">Yu Z., Zhou N., Li A., Chen J., Chen H., He C., et al. Performance assessment of the SAPS II and SOFA scoring systems in Hanta virus Hemorrhagic Fever with Renal Syndrome. International Journal of Infectious Diseases. 2017. Vol. 63. P. 88-94. doi: 10.1016/j.ijid.2017.08.003</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Zhou X., Obuchowski N., McClish D. Statistical Methods in Diagnostic Medicine. New York: John Wiley &amp; Sons, 2002.</mixed-citation><mixed-citation xml:lang="ru">Murphy K., Travers P., Walport M., editors. Janeway’s Immunobiology. 7nd ed. NewYork: Garland Science, 2011.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Yarilin A.A. Immunology. Moscow: GEOTAR Media. 2910. (in Russ).</mixed-citation><mixed-citation xml:lang="ru">Zhou X., Obuchowski N., McClish D. Statistical Methods in Diagnostic Medicine. New York: John Wiley &amp; Sons, 2002.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Rouse B.T., Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome? Nature Reviews Immunology. 2010;10(7):514—526. doi: 10.1938/nri2802</mixed-citation><mixed-citation xml:lang="ru">Ярилин А.А. Иммунология. М.: ГЭОТАР-Медиа, 2010.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Terajima M., Ennis F.A. T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever renal syndrome. Viruses. 2011;3(7):1059—1073. doi: 10.3390/v3071059</mixed-citation><mixed-citation xml:lang="ru">Rouse B.T., Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome? Nature Reviews Immunology. 2010. Vol. 10. N 7. P. 514-526.doi: 10.1938/nri2802</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Lindgren T., Ahlm C., Mohamed N., Evander N., Ljunggren H-G., Bjorkstrom N.K. Longitudinal analysis of the human T cell response during acute hantavirus infection. Journal of Virology. 2011;85(19):10252—10260. doi: 10.1128/JVI.05548—11</mixed-citation><mixed-citation xml:lang="ru">Terajima M., Ennis F.A. T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever renal syndrome. Viruses. 2011. Vol. 3. N 7. P. 1059-1073. doi: 10.3390/v3071059</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Xie M., Dong Y., Zhou Y., Ren X. Levels of HTNV-specific CD8+T lymphocytes in PBMC from the patients with hemorrhagic fever with renal syndrome. Internal and Emergency Medicine. 2013;8(6):503—508. doi: 10.1007/s11739—011—0633—4</mixed-citation><mixed-citation xml:lang="ru">Lindgren T., Ahlm C., Mohamed N., Evander N., Ljunggren H.-G., Bjorkstrom N.K. Longitudinal analysis of the human T cell response during acute hantavirus infection. Journal of Virology. 2011. Vol. 85. N 19. P. 10252-10260. doi: 10.1128/JVI.05548-11</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Mustonen J., Helin H., Pietila K., Brummer-Korvenkontio M., Hedman K., Vaheri A., et al. Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clinical Nephrology. 1994;41(3):121—126.</mixed-citation><mixed-citation xml:lang="ru">Xie M., Dong Y., Zhou Y., Ren X. Levels of HTNV-specific CD8+T lymphocytes in PBMC from the patients with hemorrhagic fever with renal syndrome. Internal and Emergency Medicine. 2013. Vol. 8. N 6. P. 503-508. doi: 10.1007/s11739-011-0633-4</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Shimizu K., Yoshimatsu K., Taruishi M., Tsuda Y., Arikawa J. Involvement of CD8+ T cells in the development of renal hemorrhage in a mouse model of hemorrhagic fever with renal syndrome. Archives of Virology. 2018;163(6):1577—1584. doi: 10.1007/s00705—018—3786-x</mixed-citation><mixed-citation xml:lang="ru">Mustonen J., Helin H., Pietila K., Brummer-Korvenkontio M., Hedman K., Vaheri A. et al. Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clinical Nephrology. 1994. Vol. 41. N 3. P. 121-126.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Walsh K.B., Lanier L.L., Lane T.E. NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis. Journal of Virology. 2008;82(6):3031—3044. doi: 10.1128/ JVI.02033—07</mixed-citation><mixed-citation xml:lang="ru">Shimizu K., Yoshimatsu K., Taruishi M., Tsuda Y., Arikawa J. Involvement of CD8+ T cells in the development of renal hemorrhage in a mouse model of hemorrhagic fever with renal syndrome. Archives of Viroljgy. 2018. Vol. 163. N 6. P. 1577-1584. doi: 10.1007/s00705-018-3786-x</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Sepiashvili R.I., Balmasova I.P. Natural killer cells and their receptors specific to MHC—I. Immunology. 2007;27(1):46—51. (in Russ).</mixed-citation><mixed-citation xml:lang="ru">Walsh K.B., Lanier L.L., Lane T.E. NKG2Dreceptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis. Journal of Virology. 2008. Vol. 82. N 6. P. 3031-3044. doi: 10.1128/ JVI.02033-07</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">Lee H.M., Bautista J.L., Hsieh C.S. Thymic and peripheral differentiation of regulatory T cells. Advаnces of Immunology. 2011;112:25—71. doi: 10.1016/B978—0—12—387827— 4.00002—4</mixed-citation><mixed-citation xml:lang="ru">Cепиашвили Р.И., Балмасова И.П. Естественные киллеры и их рецепторы, специфичные к MHC-I. Иммунология. 2007. Т. 27. № 1. С. 46-51.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">Gernoux G., Wilson J.M., Mueller C. Regulatory and Exhausted T Cell Responses to AAV Capsid. Human Gene Therapy. 2017;28(4):338—349. doi: 10.1089/hum.2017.022</mixed-citation><mixed-citation xml:lang="ru">Lee H.M., Bautista J.L., Hsieh C.S. Thymic and peripheral differentiation of regulatory T cells. Advаnces of Immunology. 2011. Vol. 112. P. 25-71. doi: 10.1016/B978-0-12-387827- 4.00002-4</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><mixed-citation>Gernoux G., Wilson J.M., Mueller C. Regulatory and Exhausted T Cell Responses to AAV Capsid. Human Gene Therapy. 2017. Vol. 28. N4. P. 338-349. doi: 10.1089/hum.2017.022</mixed-citation></ref></ref-list></back></article>
